SCHEMBL7190358

SCHEMBL7190358

CCCOc1cc(/C=C/C(=O)c2cc(OCCC)cc(OCCC)c2OCCC)c(OCCC)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.47
CYP1B1 Q16678 1/20 0.47
DPP4 P27487 3/20 0.46
PDE4A P27815 1/20 0.45
PDE4B Q07343 1/20 0.45
PDE4C Q08493 1/20 0.45
PDE4D Q08499 1/20 0.45
MAPT P10636 2/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43
TUBB3 Q13509 1/20 0.43
TUBB2A Q13885 1/20 0.43
TUBB8 Q3ZCM7 1/20 0.43
TUBA3E Q6PEY2 1/20 0.43
TUBA1A Q71U36 1/20 0.43
TUBA1C Q9BQE3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7190363 1.00 CYP1A1 (0.47) CYP1A1CYP1B1DPP4PDE4APDE4B
SCHEMBL7193955 0.94 DPP4 (0.47) CYP1A1CYP1B1DPP4PDE4APDE4B
SCHEMBL7193960 0.94 DPP4 (0.47) CYP1A1CYP1B1DPP4PDE4APDE4B
SCHEMBL7187226 0.93 PDE4A (0.46) CYP1A1CYP1B1DPP4PDE4APDE4B
SCHEMBL7194867 0.92 PDE4A (0.46) CYP1A1CYP1B1DPP4PDE4APDE4B
SCHEMBL7190298 0.89 AR (0.47) CYP1A1CYP1B1DPP4PDE4APDE4B
SCHEMBL7190293 0.89 AR (0.47) CYP1A1CYP1B1DPP4PDE4APDE4B
SCHEMBL7193922 0.88 CYP1A1 (0.47) CYP1A1CYP1B1DPP4PDE4APDE4B
SCHEMBL7193914 0.88 CYP1A1 (0.47) CYP1A1CYP1B1DPP4PDE4APDE4B
SCHEMBL7198127 0.88 AR (0.51) CYP1A1CYP1B1DPP4PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones STATENS SERUM INSTITUTE (DK) 2003-04-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030065039-A1 Biologically active 1,3-bis-aromatic-prop-2-en-1-ones, 1,3-bis-aromatic-propan-1-ones, and 1,3-bis-aromatic-prop-2-yn-1-ones AKR1C3, AKR1C1, AKR1A1 CYP1A1 32/4885CYP1B1 25/4885DPP4 1733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.